Glycolysis rate-limiting enzymes: novel potential regulators of rheumatoid arthritis pathogenesis

J Zuo, J Tang, M Lu, Z Zhou, Y Li, H Tian, E Liu… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a classic autoimmune disease characterized by uncontrolled
synovial proliferation, pannus formation, cartilage injury, and bone destruction. The specific …

Structure, regulation, and biological functions of TIGAR and its role in diseases

J Tang, L Chen, Z Qin, R Sheng - Acta Pharmacologica Sinica, 2021 - nature.com
TIGAR (TP53-induced glycolysis and apoptosis regulator) is the downstream target gene of
p53, contains a functional sequence similar to 6-phosphofructose kinase/fructose-2, 6 …

NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease

H Berven, S Kverneng, E Sheard, M Søgnen… - Nature …, 2023 - nature.com
Nicotinamide adenine dinucleotide (NAD) replenishment therapy using nicotinamide
riboside (NR) shows promise for Parkinson's disease (PD) and other neurodegenerative …

Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure

K Qian, J Tang, YJ Ling, M Zhou, XX Yan, Y Xie… - …, 2023 - thelancet.com
Background Therapies are urgently required to ameliorate pathological cardiac hypertrophy
and enhance cardiac function in heart failure. Our preliminary experiments have …

Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways

JS Park, K Choe, HJ Lee, TJ Park, MO Kim - Journal of biomedical science, 2023 - Springer
Background Parkinson's disease (PD) is the second most frequent age-related
neurodegenerative disorder and is characterized by the loss of dopaminergic neurons. Both …

p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T α-synuclein model of Parkinson's disease

C Gui, Y Ren, J Chen, X Wu, K Mao, H Li, H Yu… - Toxicology and applied …, 2020 - Elsevier
Abnormal accumulation of α-synuclein and mitochondria dynamics dysfunction are
considered to be implicated in the pathogenesis of Parkinson's disease. However, the …

MicroRNA-181a–2–3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson's disease by inhibiting EGR1 and …

J Ma, X Shi, M Li, S Chen, Q Gu, J Zheng, D Li… - Cell Death …, 2022 - nature.com
The current study investigated the physiological mechanisms by which extracellular vesicle
(EV)-encapsulated miR-181a–2–3p derived from mesenchymal stem cells (MSCs) might …

Metal chelation therapy and Parkinson's disease: A critical review on the thermodynamics of complex formation between relevant metal ions and promising or …

M Tosato, V Di Marco - Biomolecules, 2019 - mdpi.com
The present review reports a list of approximately 800 compounds which have been used,
tested or proposed for Parkinson's disease (PD) therapy in the year range 2014–2019 …

NADPH oxidases in the central nervous system: regional and cellular localization and the possible link to brain diseases

J Fang, R Sheng, ZH Qin - Antioxidants & Redox Signaling, 2021 - liebertpub.com
Significance: The significant role of reduced nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase (Nox) in signal transduction is mediated by the production of reactive …

Targeting neuroinflammation to treat cerebral ischemia-the role of TIGAR/NADPH axis

QQ Li, JY Li, M Zhou, ZH Qin, R Sheng - Neurochemistry International, 2021 - Elsevier
Cerebral ischemia is a disease of ischemic necrosis of brain tissue caused by intracranial
artery stenosis or occlusion and cerebral artery embolization. Neuroinflammation plays an …